Inhibition of angiogenesis by propolis
- Authors
- Song, YS; Park, EH; Jung, KJ; Jin, CB
- Issue Date
- Aug-2002
- Publisher
- PHARMACEUTICAL SOCIETY KOREA
- Keywords
- propolis; caffeic acid phenethyl ester; angiogenesis; chorioallantoic membrane; calf pulmonary arterial endothelial cells
- Citation
- ARCHIVES OF PHARMACAL RESEARCH, v.25, no.4, pp 500 - 504
- Pages
- 5
- Journal Title
- ARCHIVES OF PHARMACAL RESEARCH
- Volume
- 25
- Number
- 4
- Start Page
- 500
- End Page
- 504
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/16406
- DOI
- 10.1007/BF02976609
- ISSN
- 0253-6269
1976-3786
- Abstract
- Propolis, obtained from honeybee hives, has been used in Oriental folk medicine as an anti-inflammatory, anti-carcinogenic, and immunomodulatory agent. There is considerable evidence suggesting that angiogenesis and chronic inflammation are codependent. Blockage of angiogenesis results in an anti-inflammatory effect. Ethanol (EEP) and ether extracts of propolis (REP), and caffeic acid phenethyl ester (CAPE), an active component of propolis, were examined for their anti-angiogenic activities using the chick embryo chorioallantoic membrane (CAM), and the calf pulmonary arterial endothelial (CPAE) cell proliferation, assays. The presence of EEP REP and CAPE inhibited angiogenesis in the CAM assay and the proliferation of CPAE cells. The results suggest that anti-angiogenic activities of EEP, REP and CAPE are also responsible for their anti-inflammatory effect.
- Files in This Item
-
Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.